US ex rel Campie v. Gilead Sciences, Inc.

E-Law Admin/ Juli 7, 2017/ Arzneimittelrecht Schweiz/ 0Kommentare

US ex rel Campie v. Gilead Sciences, Inc., 15-16380

Reversing the district court’s dismissal of claims under the False Claims Act by realtors against their former employer who made false statements about its compliance with FDA regulations regarding certain HIV drugs resulting in the receipt of billions of dollars from the federal government and alleging retaliation against the complaining realtor, holding that the realtors adequately pled a claim for retaliation.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/07/07



  • United States Ninth Circuit


e-Law Trainer

Share this Post

Hinterlasse einen Kommentar